InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Juvenescence Ltd. Director active across 2 companies, notably AgeX Therapeutics, Inc.. Aggregated, 2 reports have been logged. History available since 14 March 2023. The latest transaction was filed on 6 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations